United Health Products (UEEC) Research & Development (2018 - 2026)

United Health Products (UEEC) has reported Research & Development for 9 consecutive years, with $3852.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 95.24% year-over-year to $3852.0 in Q2 2026; TTM through Jun 2026 was $89047.0, a 76.06% decrease from a year earlier, with the FY2025 full-year figure at $269867.0, down 24.18% from the prior year.
• Research & Development was $3852.0 for Q2 2026 at United Health Products, down from $12562.0 in the prior quarter.
• Over five years, Research & Development peaked at $218676.0 in Q1 2023 and troughed at $3852.0 in Q2 2026.
• A 5-year average of $103643.9 and a median of $106946.0 in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 988.11% in 2022 and plunged 95.24% in 2026, its largest moves.
• Over 5 years, Research & Development stood at $209620.0 in 2022, then slipped by 26.89% to $153260.0 in 2023, then dropped by 29.02% to $108779.0 in 2024, then sank by 56.52% to $47299.0 in 2025, then plunged by 91.86% to $3852.0 in 2026.
• The last three Research & Development figures came in at $3852.0 (Q2 2026), $12562.0 (Q1 2026), and $47299.0 (Q4 2025), per Business Quant data.